ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 163 filers reported holding ADMA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,501,238 | +1.0% | 419,340 | +4.1% | 0.00% | – |
| Q2 2023 | $1,485,985 | +21.4% | 402,706 | +8.9% | 0.00% | – |
| Q1 2023 | $1,224,243 | -14.7% | 369,862 | -0.1% | 0.00% | – |
| Q4 2022 | $1,436,000 | +57.8% | 370,232 | -1.0% | 0.00% | – |
| Q3 2022 | $910,000 | +19.1% | 374,156 | -3.0% | 0.00% | – |
| Q2 2022 | $764,000 | +1636.4% | 385,573 | +1701.7% | 0.00% | – |
| Q4 2020 | $44,000 | -62.1% | 21,400 | -56.0% | 0.00% | – |
| Q3 2020 | $116,000 | -14.7% | 48,680 | +4.9% | 0.00% | – |
| Q2 2020 | $136,000 | +46.2% | 46,410 | +43.7% | 0.00% | – |
| Q1 2020 | $93,000 | -1.1% | 32,300 | +36.9% | 0.00% | – |
| Q4 2019 | $94,000 | -54.1% | 23,600 | -48.7% | 0.00% | – |
| Q3 2019 | $205,000 | +7.3% | 46,005 | -6.9% | 0.00% | – |
| Q2 2019 | $191,000 | – | 49,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |